1 completed, 1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow ASKA Pharmaceutical Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial Rifaximin oral tablet, Placebo oral tablet - Chronic Intestinal Pseudo-obstruction | Phase 2 | Unknown | Yokohama City University | 12 | 2019-12-25 | 2021-06-21 |
| Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis TAK-385, Leuprorelin acetate - Endometriosis | Phase 3 | Completed | ASKA Pharmaceutical Co., Ltd. | 335 | 2019-05-08 | 2020-12-11 |
Endometriosis (1) · Intestinal Pseudo-Obstruction (1) · Scleroderma, Systemic (1)
Leuprolide (1) · Rifaximin (1) · relugolix (1)
Japan (2)